Population
Human umbilical vein endothelial cells (HUVECs)
Comparison
Methylglyoxal treatment for 20 min to 24 h vs Untreated cells
Design
Preclinical
Follow-up
up to 24 hours
Authors
Loading...
MGO may promote endothelial injury in diabetes; leaves open JNK/p38 targeting pending human validation.
Methylglyoxal mediates vascular inflammation in human endothelial cells via JNK and p38 pathways, providing a potential mechanism for diabetes-associated endothelial injury.
Yamawaki et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: